Shaofeng Duan
Research Subjects
Shaofeng Duan has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Feng Feng
Department of Radiology, Affiliated Tumor Hospital of Nantong University, Nantong, China
6 shared publications - Hui Peng
Department of Radiology, Affiliated Tumor Hospital of Nantong University , Nantong, PR China
4 shared publications - Manman Li
The Yancheng Clinical College of Xuzhou Medical University, The First people’s Hospital of Yancheng, Yancheng, China
4 shared publications - Qiaoling Chen
Department of Radiology, Changhai Hospital, The Navy Medical University, Shanghai, China
4 shared publications - Ting Xue
Department of Radiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China
4 shared publications - Lili Guo
Department of Radiology, The Affiliated Huai’an NO.1 People’s Hospital of Nanjing Medical University, Huai’an, China
3 shared publications
Latest Publications
- 1 February 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 314 (2) , e240876
SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events
SARS-CoV-2 infection was associated with coronary atherosclerotic plaque progression, as assessed by coronary CT angiography, and worse cardiovascular outcomes.
- 1 February 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 314 (2) , e240876
SARS-CoV-2 Infection Association with Atherosclerotic Plaque Progression at Coronary CT Angiography and Adverse Cardiovascular Events
SARS-CoV-2 infection was associated with coronary atherosclerotic plaque progression, as assessed by coronary CT angiography, and worse cardiovascular outcomes.
- 17 June 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (10) , e1214-e1225
Analysis of postoperative recurrence-free survival in non–small cell lung cancer patients based on consensus clustering
- 17 June 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (10) , e1214-e1225
Analysis of postoperative recurrence-free survival in non–small cell lung cancer patients based on consensus clustering
- 16 May 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (9) , e1089-e1100
Prediction of programmed death-1 expression status in non–small cell lung cancer based on intratumoural and peritumoral computed tomography (CT) radiomics nomogram
- 16 May 2024
- Published by Elsevier in Clinical Radiology
- Vol. 79 (9) , e1089-e1100
Prediction of programmed death-1 expression status in non–small cell lung cancer based on intratumoural and peritumoral computed tomography (CT) radiomics nomogram
- Open Access
- 10 January 2024
- Published by Springer Nature in Journal of Imaging Informatics in Medicine
- Vol. 37 (2) , 520-535
CT-Based Intratumoral and Peritumoral Radiomics Nomograms for the Preoperative Prediction of Spread Through Air Spaces in Clinical Stage IA Non-small Cell Lung Cancer
The study aims to investigate the value of intratumoral and peritumoral radiomics and clinical-radiological features for predicting spread through air spaces (STAS) in patients with clinical stage IA non-small cell lung cancer (NSCLC). A total of 336 NSCLC patients from our hospital were randomly divided into the training cohort (n = 236) and the internal validation cohort (n = 100) at a ratio of 7:3, and 69 patients from the other two external hospitals were collected as the external validation cohort. Univariate and multivariate analyses were used to select clinical-radiological features and construct a clinical model. The GTV, PTV5, PTV10, PTV15, PTV20, GPTV5, GPTV10, GPTV15, and GPTV20 models were constructed based on intratumoral and peritumoral (5 mm, 10 mm, 15 mm, 20 mm) radiomics features. Additionally, the radscore of the optimal radiomics model and clinical-radiological predictors were used to construct a combined model and plot a nomogram. Lastly, the ROC curve and AUC value were used to evaluate the diagnostic performance of the model. Tumor density type (OR = 6.738) and distal ribbon sign (OR = 5.141) were independent risk factors for the occurrence of STAS. The GPTV10 model outperformed the other radiomics models, and its AUC values were 0.887, 0.876, and 0.868 in the three cohorts. The AUC values of the combined model constructed based on GPTV10 radscore and clinical-radiological predictors were 0.901, 0.875, and 0.878. DeLong test results revealed that the combined model was superior to the clinical model in the three cohorts. The nomogram based on GPTV10 radscore and clinical-radiological features exhibited high predictive efficiency for STAS status in NSCLC.
- 10 January 2024
- Published by Springer Nature in Journal of Imaging Informatics in Medicine
- Vol. 37 (2) , 520-535
Open AccessCT-Based Intratumoral and Peritumoral Radiomics Nomograms for the Preoperative Prediction of Spread Through Air Spaces in Clinical Stage IA Non-small Cell Lung Cancer
The study aims to investigate the value of intratumoral and peritumoral radiomics and clinical-radiological features for predicting spread through air spaces (STAS) in patients with clinical stage IA non-small cell lung cancer (NSCLC). A total of 336 NSCLC patients from our hospital were randomly divided into the training cohort (n = 236) and the internal validation cohort (n = 100) at a ratio of 7:3, and 69 patients from the other two external hospitals were collected as the external validation cohort. Univariate and multivariate analyses were used to select clinical-radiological features and construct a clinical model. The GTV, PTV5, PTV10, PTV15, PTV20, GPTV5, GPTV10, GPTV15, and GPTV20 models were constructed based on intratumoral and peritumoral (5 mm, 10 mm, 15 mm, 20 mm) radiomics features. Additionally, the radscore of the optimal radiomics model and clinical-radiological predictors were used to construct a combined model and plot a nomogram. Lastly, the ROC curve and AUC value were used to evaluate the diagnostic performance of the model. Tumor density type (OR = 6.738) and distal ribbon sign (OR = 5.141) were independent risk factors for the occurrence of STAS. The GPTV10 model outperformed the other radiomics models, and its AUC values were 0.887, 0.876, and 0.868 in the three cohorts. The AUC values of the combined model constructed based on GPTV10 radscore and clinical-radiological predictors were 0.901, 0.875, and 0.878. DeLong test results revealed that the combined model was superior to the clinical model in the three cohorts. The nomogram based on GPTV10 radscore and clinical-radiological features exhibited high predictive efficiency for STAS status in NSCLC.
- 4 January 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (4) , 1074-1083
A deep learning model based on MRI for prediction of vessels encapsulating tumour clusters and prognosis in hepatocellular carcinoma
Purpose This study aimed to build and evaluate a deep learning (DL) model to predict vessels encapsulating tumor clusters (VETC) and prognosis preoperatively in patients with hepatocellular carcinoma (HCC). Methods 320 pathologically confirmed HCC patients (58 women and 262 men) from two hospitals were included in this retrospective study. Institution 1 (n = 219) and Institution 2 (n = 101) served as the training and external test cohorts, respectively. Tumors were evaluated three-dimensionally and regions of interest were segmented manually in the arterial, portal venous, and delayed phases (AP, PP, and DP). Three ResNet-34 DL models were developed, consisting of three models based on a single sequence. The fusion model was developed by inputting the prediction probability of the output from the three single-sequence models into logistic regression. The area under the receiver operating characteristic curve (AUC) was used to compare performance, and the Delong test was used to compare AUCs. Early recurrence (ER) was defined as recurrence within two years of surgery and early recurrence-free survival (ERFS) rate was evaluated by Kaplan–Meier survival analysis. Results Among the 320 HCC patients, 227 were VETC− and 93 were VETC+ . In the external test cohort, the fusion model showed an AUC of 0.772, a sensitivity of 0.80, and a specificity of 0.61. The fusion model-based prediction of VETC high-risk and low-risk categories exhibits a significant difference in ERFS rates, akin to the outcomes observed in VETC + and VETC− confirmed through pathological analyses (p < 0.05). Conclusions A DL framework based on ResNet-34 has demonstrated potential in facilitating non-invasive prediction of VETC as well as patient prognosis. Graphical abstract
- 4 January 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (4) , 1074-1083
A deep learning model based on MRI for prediction of vessels encapsulating tumour clusters and prognosis in hepatocellular carcinoma
Purpose This study aimed to build and evaluate a deep learning (DL) model to predict vessels encapsulating tumor clusters (VETC) and prognosis preoperatively in patients with hepatocellular carcinoma (HCC). Methods 320 pathologically confirmed HCC patients (58 women and 262 men) from two hospitals were included in this retrospective study. Institution 1 (n = 219) and Institution 2 (n = 101) served as the training and external test cohorts, respectively. Tumors were evaluated three-dimensionally and regions of interest were segmented manually in the arterial, portal venous, and delayed phases (AP, PP, and DP). Three ResNet-34 DL models were developed, consisting of three models based on a single sequence. The fusion model was developed by inputting the prediction probability of the output from the three single-sequence models into logistic regression. The area under the receiver operating characteristic curve (AUC) was used to compare performance, and the Delong test was used to compare AUCs. Early recurrence (ER) was defined as recurrence within two years of surgery and early recurrence-free survival (ERFS) rate was evaluated by Kaplan–Meier survival analysis. Results Among the 320 HCC patients, 227 were VETC− and 93 were VETC+ . In the external test cohort, the fusion model showed an AUC of 0.772, a sensitivity of 0.80, and a specificity of 0.61. The fusion model-based prediction of VETC high-risk and low-risk categories exhibits a significant difference in ERFS rates, akin to the outcomes observed in VETC + and VETC− confirmed through pathological analyses (p < 0.05). Conclusions A DL framework based on ResNet-34 has demonstrated potential in facilitating non-invasive prediction of VETC as well as patient prognosis. Graphical abstract
- Open Access
- 1 January 2024
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 23
Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging
Background: Hepatocellular carcinoma (HCC) is a serious health concern because of its high morbidity and mortality. The prognosis of HCC largely depends on the disease stage at diagnosis. Computed tomography (CT) image textural analysis is an image analysis technique that has emerged in recent years. Objective: To probe the feasibility of a CT radiomic model for predicting early (stages 0, A) and intermediate (stage B) HCC using Barcelona Clinic Liver Cancer (BCLC) staging. Methods: A total of 190 patients with stages 0, A, or B HCC according to CT-enhanced arterial and portal vein phase images were retrospectively assessed. The lesions were delineated manually to construct a region of interest (ROI) consisting of the entire tumor mass. Consequently, the textural profiles of the ROIs were extracted by specific software. Least absolute shrinkage and selection operator dimensionality reduction was used to screen the textural profiles and obtain the area under the receiver operating characteristic curve values. Results: Within the test cohort, the area under the curve (AUC) values associated with arterial-phase images and BCLC stages 0, A, and B disease were 0.99, 0.98, and 0.99, respectively. The overall accuracy rate was 92.7%. The AUC values associated with portal vein phase images and BCLC stages 0, A, and B disease were 0.98, 0.95, and 0.99, respectively, with an overall accuracy of 90.9%. Conclusion: The CT radiomic model can be used to predict the BCLC stage of early-stage and intermediate-stage HCC.
- 1 January 2024
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 23
Open AccessFeasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging
Background: Hepatocellular carcinoma (HCC) is a serious health concern because of its high morbidity and mortality. The prognosis of HCC largely depends on the disease stage at diagnosis. Computed tomography (CT) image textural analysis is an image analysis technique that has emerged in recent years. Objective: To probe the feasibility of a CT radiomic model for predicting early (stages 0, A) and intermediate (stage B) HCC using Barcelona Clinic Liver Cancer (BCLC) staging. Methods: A total of 190 patients with stages 0, A, or B HCC according to CT-enhanced arterial and portal vein phase images were retrospectively assessed. The lesions were delineated manually to construct a region of interest (ROI) consisting of the entire tumor mass. Consequently, the textural profiles of the ROIs were extracted by specific software. Least absolute shrinkage and selection operator dimensionality reduction was used to screen the textural profiles and obtain the area under the receiver operating characteristic curve values. Results: Within the test cohort, the area under the curve (AUC) values associated with arterial-phase images and BCLC stages 0, A, and B disease were 0.99, 0.98, and 0.99, respectively. The overall accuracy rate was 92.7%. The AUC values associated with portal vein phase images and BCLC stages 0, A, and B disease were 0.98, 0.95, and 0.99, respectively, with an overall accuracy of 90.9%. Conclusion: The CT radiomic model can be used to predict the BCLC stage of early-stage and intermediate-stage HCC.
- Open Access
- 13 September 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (18) , 2937
Development and Validation of a Radiomics Nomogram for Liver Metastases Originating from Gastric and Colorectal Cancer
The origin of metastatic liver tumours (arising from gastric or colorectal sources) is closely linked to treatment choices and survival prospects. However, in some instances, the primary lesion remains elusive even after an exhaustive diagnostic investigation. Consequently, we have devised and validated a radiomics nomogram for ascertaining the primary origin of liver metastases stemming from gastric cancer (GCLMs) and colorectal cancer (CCLMs). This retrospective study encompassed patients diagnosed with either GCLMs or CCLMs, comprising a total of 277 GCLM cases and 278 CCLM cases. Radiomic characteristics were derived from venous phase computed tomography (CT) scans, and a radiomics signature (RS) was computed. Multivariable regression analysis demonstrated that gender (OR = 3.457; 95% CI: 2.102–5.684; p < 0.001), haemoglobin levels (OR = 0.976; 95% CI: 0.967–0.986; p < 0.001), carcinoembryonic antigen (CEA) levels (OR = 0.500; 95% CI: 0.307–0.814; p = 0.005), and RS (OR = 2.147; 95% CI: 1.127–4.091; p = 0.020) exhibited independent associations with GCLMs as compared to CCLMs. The nomogram, combining RS with clinical variables, demonstrated strong discriminatory power in both the training (AUC = 0.71) and validation (AUC = 0.78) cohorts. The calibration curve, decision curve analysis, and clinical impact curves revealed the clinical utility of this nomogram and substantiated its enhanced diagnostic performance.
- 13 September 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (18) , 2937
Open AccessDevelopment and Validation of a Radiomics Nomogram for Liver Metastases Originating from Gastric and Colorectal Cancer
The origin of metastatic liver tumours (arising from gastric or colorectal sources) is closely linked to treatment choices and survival prospects. However, in some instances, the primary lesion remains elusive even after an exhaustive diagnostic investigation. Consequently, we have devised and validated a radiomics nomogram for ascertaining the primary origin of liver metastases stemming from gastric cancer (GCLMs) and colorectal cancer (CCLMs). This retrospective study encompassed patients diagnosed with either GCLMs or CCLMs, comprising a total of 277 GCLM cases and 278 CCLM cases. Radiomic characteristics were derived from venous phase computed tomography (CT) scans, and a radiomics signature (RS) was computed. Multivariable regression analysis demonstrated that gender (OR = 3.457; 95% CI: 2.102–5.684; p < 0.001), haemoglobin levels (OR = 0.976; 95% CI: 0.967–0.986; p < 0.001), carcinoembryonic antigen (CEA) levels (OR = 0.500; 95% CI: 0.307–0.814; p = 0.005), and RS (OR = 2.147; 95% CI: 1.127–4.091; p = 0.020) exhibited independent associations with GCLMs as compared to CCLMs. The nomogram, combining RS with clinical variables, demonstrated strong discriminatory power in both the training (AUC = 0.71) and validation (AUC = 0.78) cohorts. The calibration curve, decision curve analysis, and clinical impact curves revealed the clinical utility of this nomogram and substantiated its enhanced diagnostic performance.
- Open Access
- 24 July 2023
- Published by Springer Nature in Cancer Imaging
- Vol. 23 (1) , 1-11
Assessing synchronous ovarian metastasis in gastric cancer patients using a clinical-radiomics nomogram based on baseline abdominal contrast-enhanced CT: a two-center study
Background: To build and validate a radiomics nomogram based on preoperative CT scans and clinical data for detecting synchronous ovarian metastasis (SOM) in female gastric cancer (GC) cases. Methods: Pathologically confirmed GC cases in 2 cohorts were retrospectively enrolled. All cases had presurgical abdominal contrast-enhanced CT and pelvis contrast-enhanced MRI and pathological examinations for any suspicious ovarian lesions detected by MRI. Cohort 1 cases (n = 101) were included as the training set. Radiomics features were obtained to develop a radscore. A nomogram combining the radscore and clinical factors was built to detect SOM. The bootstrap method was carried out in cohort 1 as internal validation. External validation was carried out in cohort 2 (n = 46). Receiver operating characteristic (ROC) curve analysis, decision curve analysis (DCA) and the confusion matrix were utilized to assess the performances of the radscore, nomogram and subjective evaluation model. Results: The nomogram, which combined age and the radscore, displayed a higher AUC than the radscore and subjective evaluation (0.910 vs 0.827 vs 0.773) in the training cohort. In the external validation cohort, the nomogram also had a higher AUC than the radscore and subjective evaluation (0.850 vs 0.790 vs 0.675). DCA and the confusion matrix confirmed the nomogram was superior to the radscore in both cohorts. Conclusions: This pilot study showed that a nomogram model combining the radscore and clinical characteristics is useful in detecting SOM in female GC cases. It may be applied to improve clinical treatment and is superior to subjective evaluation or the radscore alone.
- 24 July 2023
- Published by Springer Nature in Cancer Imaging
- Vol. 23 (1) , 1-11
Open AccessAssessing synchronous ovarian metastasis in gastric cancer patients using a clinical-radiomics nomogram based on baseline abdominal contrast-enhanced CT: a two-center study
Background: To build and validate a radiomics nomogram based on preoperative CT scans and clinical data for detecting synchronous ovarian metastasis (SOM) in female gastric cancer (GC) cases. Methods: Pathologically confirmed GC cases in 2 cohorts were retrospectively enrolled. All cases had presurgical abdominal contrast-enhanced CT and pelvis contrast-enhanced MRI and pathological examinations for any suspicious ovarian lesions detected by MRI. Cohort 1 cases (n = 101) were included as the training set. Radiomics features were obtained to develop a radscore. A nomogram combining the radscore and clinical factors was built to detect SOM. The bootstrap method was carried out in cohort 1 as internal validation. External validation was carried out in cohort 2 (n = 46). Receiver operating characteristic (ROC) curve analysis, decision curve analysis (DCA) and the confusion matrix were utilized to assess the performances of the radscore, nomogram and subjective evaluation model. Results: The nomogram, which combined age and the radscore, displayed a higher AUC than the radscore and subjective evaluation (0.910 vs 0.827 vs 0.773) in the training cohort. In the external validation cohort, the nomogram also had a higher AUC than the radscore and subjective evaluation (0.850 vs 0.790 vs 0.675). DCA and the confusion matrix confirmed the nomogram was superior to the radscore in both cohorts. Conclusions: This pilot study showed that a nomogram model combining the radscore and clinical characteristics is useful in detecting SOM in female GC cases. It may be applied to improve clinical treatment and is superior to subjective evaluation or the radscore alone.
- Open Access
- 19 April 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (8) , 1479
A CT-Based Radiomics Model for Prediction of Prognosis in Patients with Novel Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Study
This study aimed to develop a computed tomography (CT)-based radiomics model to predict the outcome of COVID-19 pneumonia. In total of 44 patients with confirmed diagnosis of COVID-19 were retrospectively enrolled in this study. The radiomics model and subtracted radiomics model were developed to assess the prognosis of COVID-19 and compare differences between the aggravate and relief groups. Each radiomic signature consisted of 10 selected features and showed good performance in differentiating between the aggravate and relief groups. The sensitivity, specificity, and accuracy of the first model were 98.1%, 97.3%, and 97.6%, respectively (AUC = 0.99). The sensitivity, specificity, and accuracy of the second model were 100%, 97.3%, and 98.4%, respectively (AUC = 1.00). There was no significant difference between the models. The radiomics models revealed good performance for predicting the outcome of COVID-19 in the early stage. The CT-based radiomic signature can provide valuable information to identify potential severe COVID-19 patients and aid clinical decisions.
- 19 April 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (8) , 1479
Open AccessA CT-Based Radiomics Model for Prediction of Prognosis in Patients with Novel Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Study
This study aimed to develop a computed tomography (CT)-based radiomics model to predict the outcome of COVID-19 pneumonia. In total of 44 patients with confirmed diagnosis of COVID-19 were retrospectively enrolled in this study. The radiomics model and subtracted radiomics model were developed to assess the prognosis of COVID-19 and compare differences between the aggravate and relief groups. Each radiomic signature consisted of 10 selected features and showed good performance in differentiating between the aggravate and relief groups. The sensitivity, specificity, and accuracy of the first model were 98.1%, 97.3%, and 97.6%, respectively (AUC = 0.99). The sensitivity, specificity, and accuracy of the second model were 100%, 97.3%, and 98.4%, respectively (AUC = 1.00). There was no significant difference between the models. The radiomics models revealed good performance for predicting the outcome of COVID-19 in the early stage. The CT-based radiomic signature can provide valuable information to identify potential severe COVID-19 patients and aid clinical decisions.
- Open Access
- 1 February 2023
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 96 (1143) , 20220068
Intratumoral and peritumoral radiomics for preoperatively predicting the axillary non-sentinel lymph node metastasis in breast cancer on the basis of contrast-enhanced mammography: a multicenter study
Objective: To develop and test a contrast-enhanced mammography (CEM)-based radiomics model using intratumoral and peritumoral regions to predict non-sentinel lymph node (NSLN) metastasis in breast cancer before surgery. Methods: This multicenter study included 365 breast cancer patients with sentinel lymph node metastasis. Intratumoral regions of interest (ROIs) were manually delineated, and peritumoral ROIs (5 and 10 mm) were automatically obtained. Five models, including intratumoral model, peritumoral (5 and 10 mm) models, and intratumoral+peritumoral (5 and 10 mm) models, were constructed by support vector machine classifier on the basis of optimal features selected by variance threshold, SelectKbest, and least absolute shrinkage and selection operator algorithms. The predictive performance of radiomics models was evaluated by receiver operating characteristic curves. An external testing set was used to test the model. The Memorial Sloan Kettering Cancer Center (MSKCC) model was used to compare the predictive performance with radiomics model. Results: The intratumoral ROI and intratumoral+peritumoral 10-mm ROI-based radiomics model achieved the best performance with an area under the curve (AUC) of 0.8000 (95% confidence interval [CI]: 0.6871–0.8266) in the internal testing set. In the external testing set, the AUC of radiomics model was 0.7567 (95% CI: 0.6717–0.8678), higher than that of MSKCC model (AUC = 0.6681, 95% CI: 0.5148–0.8213) (p = 0.361). Conclusions: The intratumoral and peritumoral radiomics based on CEM had an acceptable predictive performance in predicting NSLN metastasis in breast cancer, which could be seen as a supplementary predicting tool to help clinicians make appropriate surgical plans. Advances in knowledge: The intratumoral and peritumoral CEM-based radiomics model could noninvasively predict NSLN metastasis in breast cancer patients before surgery.
- 1 February 2023
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 96 (1143) , 20220068
Open AccessIntratumoral and peritumoral radiomics for preoperatively predicting the axillary non-sentinel lymph node metastasis in breast cancer on the basis of contrast-enhanced mammography: a multicenter study
Objective: To develop and test a contrast-enhanced mammography (CEM)-based radiomics model using intratumoral and peritumoral regions to predict non-sentinel lymph node (NSLN) metastasis in breast cancer before surgery. Methods: This multicenter study included 365 breast cancer patients with sentinel lymph node metastasis. Intratumoral regions of interest (ROIs) were manually delineated, and peritumoral ROIs (5 and 10 mm) were automatically obtained. Five models, including intratumoral model, peritumoral (5 and 10 mm) models, and intratumoral+peritumoral (5 and 10 mm) models, were constructed by support vector machine classifier on the basis of optimal features selected by variance threshold, SelectKbest, and least absolute shrinkage and selection operator algorithms. The predictive performance of radiomics models was evaluated by receiver operating characteristic curves. An external testing set was used to test the model. The Memorial Sloan Kettering Cancer Center (MSKCC) model was used to compare the predictive performance with radiomics model. Results: The intratumoral ROI and intratumoral+peritumoral 10-mm ROI-based radiomics model achieved the best performance with an area under the curve (AUC) of 0.8000 (95% confidence interval [CI]: 0.6871–0.8266) in the internal testing set. In the external testing set, the AUC of radiomics model was 0.7567 (95% CI: 0.6717–0.8678), higher than that of MSKCC model (AUC = 0.6681, 95% CI: 0.5148–0.8213) (p = 0.361). Conclusions: The intratumoral and peritumoral radiomics based on CEM had an acceptable predictive performance in predicting NSLN metastasis in breast cancer, which could be seen as a supplementary predicting tool to help clinicians make appropriate surgical plans. Advances in knowledge: The intratumoral and peritumoral CEM-based radiomics model could noninvasively predict NSLN metastasis in breast cancer patients before surgery.